Hepsera (Excella GmbH)
Welcome to the PulseAid listing for the Hepsera drug offered from Excella GmbH. This Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Excella GmbH |
| NON-PROPRIETARY NAME: | Adefovir Dipivoxil |
| SUBSTANCE NAME: | ADEFOVIR DIPIVOXIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2002-09-20 |
| END MARKETING DATE: | 0000-00-00 |
Hepsera HUMAN PRESCRIPTION DRUG Details:
| Item Description | Hepsera from Excella GmbH |
| LABELER NAME: | Excella GmbH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2002-09-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 46014-0501_8b66b3f1-06d1-4afa-8bfc-af6c19fcd649 |
| PRODUCT NDC: | 46014-0501 |
| APPLICATION NUMBER: | NDA021449 |
Other ADEFOVIR DIPIVOXIL Pharmaceutical Manufacturers / Labelers:
